Overview

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this study is to determine the safety profiles, tolerability, pharmacokinetics and pharmacodynamics of HMS5552 following single ascending doses in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Hua Medicine Limited